Medtronic recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEADR LBBAP study showing a ...

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025 ...

Medtronic plc, a global leader in healthcare technology, received US Food and Drug Administration (FDA) approval for the OmniaSecure defibrillation lead for placement within the right ventricle. The ...

Adding to its Activa line of deep brain stimulation (DBS) devices, Medtronic has announced the ... a thin, insulated lead that is placed in a specific target within the brain; and an extension ...

Medtronic received approval for its OmniaSecure defibrillation lead for placement within the right ventricle, from the Food and Drug Administration. The medical technology company said Friday that ...

(RTTNews) - Medtronic plc (MDT) said that it received U.S. Food and Drug Administration approval for the OmniaSecure defibrillation lead for placement within the right ventricle. The lead ...

Medtronic recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEADR LBBAP study showing a 100% ...